The University of Texas’ MD Anderson Cancer Center, in collaboration with the National Cancer Institute and Golfers Against Cancer, is evaluating the usefulness of a blood test called CA-125 at detecting ovarian cancer at early stages in low-risk women. Cancer antigen 125 (CA-125) is a protein found at higher levels in people with ovarian and other types of cancer. The CA-125 test is frequently used to detect ovarian cancer in women at high risk for the disease, and to…
You must be logged in to read/download the full post.
The post Study to Examine if Blood Test Can Detect Cancer Early in Low-Risk Women appeared first on BioNewsFeeds.